Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2012-03-09

Clinical Trial Update: Enhanced Assisted Reproductive Technology Pregnancy Rate by Prostacyclin Analog (Iloprost)

View source ↗

Summary

Clinical trial update reporting on Iloprost, a prostacyclin analog, as a potential enhancer of pregnancy rates in assisted reproductive technology.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Iloprost (iloprost)

Snippet

Sponsor: Fertility Specialists of Houston | Conditions: Pregnancy | Status: UNKNOWN